These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 17439952)
21. An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway. Ju Z; Su M; Li D; Hong J; Im DS; Kim S; Kim E; Jung JH Mar Drugs; 2019 May; 17(6):. PubMed ID: 31151271 [TBL] [Abstract][Full Text] [Related]
22. Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages. Kim HY; Kim HK; Kim JR; Kim HS Immunol Cell Biol; 2005 Jun; 83(3):286-93. PubMed ID: 15877607 [TBL] [Abstract][Full Text] [Related]
23. 15-Deoxy-△ Kim W; Jang JH; Zhong X; Seo H; Surh YJ Front Immunol; 2021; 12():615803. PubMed ID: 33633749 [TBL] [Abstract][Full Text] [Related]
24. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. Kaplan JM; Cook JA; Hake PW; O'Connor M; Burroughs TJ; Zingarelli B Shock; 2005 Jul; 24(1):59-65. PubMed ID: 15988322 [TBL] [Abstract][Full Text] [Related]
25. PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages. Porter DW; Wolfarth M; Young SH; Rao MK; Meighan T; Barger M; Andrew ME; Huffman LJ J Toxicol Environ Health A; 2007 Dec; 70(23):1967-76. PubMed ID: 17966068 [TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes. Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742 [TBL] [Abstract][Full Text] [Related]
27. Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. Yuan Z; Liu Y; Liu Y; Zhang J; Kishimoto C; Wang Y; Ma A; Liu Z Heart; 2005 Sep; 91(9):1203-8. PubMed ID: 15774612 [TBL] [Abstract][Full Text] [Related]
29. Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma. Gandhi UH; Kaushal N; Ravindra KC; Hegde S; Nelson SM; Narayan V; Vunta H; Paulson RF; Prabhu KS J Biol Chem; 2011 Aug; 286(31):27471-82. PubMed ID: 21669866 [TBL] [Abstract][Full Text] [Related]
30. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1. Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914 [TBL] [Abstract][Full Text] [Related]
31. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665 [TBL] [Abstract][Full Text] [Related]
32. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384 [TBL] [Abstract][Full Text] [Related]
33. 15-Deoxy-Δ Na HK; Yang H; Surh YJ J Cancer Prev; 2020 Jun; 25(2):100-110. PubMed ID: 32647651 [TBL] [Abstract][Full Text] [Related]
34. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism. Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972 [TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Maggi LB; Sadeghi H; Weigand C; Scarim AL; Heitmeier MR; Corbett JA Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955 [TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells. Kaplan J; Cook JA; O'Connor M; Zingarelli B Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259 [TBL] [Abstract][Full Text] [Related]
37. miR-27b-3p, miR-181a-1-3p, and miR-326-5p are involved in the inhibition of macrophage activation in chronic liver injury. Li W; Chang N; Tian L; Yang J; Ji X; Xie J; Yang L; Li L J Mol Med (Berl); 2017 Oct; 95(10):1091-1105. PubMed ID: 28748390 [TBL] [Abstract][Full Text] [Related]
39. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Bernardo A; Levi G; Minghetti L Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800 [TBL] [Abstract][Full Text] [Related]